Encellin Announces Interim Clinical Results Showing First-in-Human Non-Fibrotic Engraftment and Viable Encapsulated Human Islets in Subjects with Type 1 Diabetes

Encellin, a biotechnology company pioneering Encapsulated Cell Replacement Therapy (ENCRT), today announced interim clinical results from its ongoing Phase 1 investigational trial (NCT06408311) in ...
Nature

Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas

Therapeutically engineered stem cells have shown promise for glioblastoma multiforme (GBM) therapy; however, key preclinical studies are urgently needed for their clinical translation. In this study, ...
Monthly Prescribing Reference

Encapsulated Rapamycin Fast Tracked for Familial Adenomatous Polyposis

Encapsulated rapamycin is expected to prevent disease progression by inhibiting mTOR, a protein kinase that has been shown to be overexpressed in FAP polyps. The Food and Drug Administration (FDA) has ...
Nature

Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide)

Controlled release from biodegradable polymers is a novel approach to replace daily painful injections of protein drugs. A major obstacle to development of these polymers is the need to retain the ...
Diabetes.co.uk

Encapsulated Islet Cells

Encapsulated islet cells is a treatment for type 1 diabetes that is currently undergoing research and development. Encapsulated islet cells can be likened to an advanced form of transplantation but ...